Osteoporosis not classified as an autoimmune disease
The immune system plays a significant role in the development of osteoporosis, a bone disease characterised by weakened bones and an increased risk of fractures.
The immune system and bone systems share similar regulatory mechanisms, and molecules supporting bone growth. In autoimmune disorders, chronic inflammation and immune dysregulation contribute to increased bone resorption and decreased bone formation, thereby promoting osteoporosis.
Immune cells like T cells and B cells secrete RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand), which stimulates osteoclast differentiation and activity, leading to enhanced bone resorption. In conditions such as estrogen deficiency (e.g., postmenopause), there is an upregulation of pro-inflammatory cytokines—including TNF-α, IL-1β, IL-6, and IL-17—that increase RANKL expression and create a chronic inflammatory state that accelerates bone loss.
Autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus are associated with persistent systemic inflammation that elevates these cytokines, thereby increasing fracture risk and reducing bone mineral density. Moreover, autoimmune diseases causing chronic inflammation alter the immune microenvironment in bone tissue, further promoting osteoclastogenesis.
Several underlying conditions, including rheumatoid arthritis, inflammatory bowel disease, and other autoimmune disorders, can increase a person's risk of developing osteoporosis. In addition, low levels of estrogen or testosterone, slender body type, certain medications, a diet low in calcium and vitamin D, and lifestyle factors such as smoking and excess alcohol consumption can also contribute to the development of osteoporosis.
It is important to note that osteoporosis is not an autoimmune condition itself, but autoimmune cells may directly affect bone density by altering bone formation. People assigned as female at birth generally have a higher risk of osteoporosis, and white and Asian females have the highest risk.
These insights highlight the immuno-inflammatory basis of osteoporosis and suggest potential therapeutic targets within immune pathways for managing or preventing osteoporosis linked to autoimmune conditions. If you have concerns about conditions that can increase your risk of osteoporosis, it is best to contact your doctor.
- The immune system's dysregulation, observed in other autoimmune disorders, increases bone resorption and decreases bone formation, consequently promoting the development of osteoporosis.
- Osteoporosis, a chronic disease, is characterized by weakened bones and an increased risk of fractures, and science suggests that the immune system significantly contributes to its development.
- Bone health is directly affected by the immune system, as autoimmune cells can alter bone density, and this insight reveals potential therapeutic targets for managing or preventing osteoporosis related to autoimmune conditions.
- Autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus, which cause persistent systemic inflammation, can increase a person's risk of developing osteoporosis, and other chronic diseases and medical-conditions may also contribute to this bone disorder.
- A person's health and wellness can be affected by various factors, including low hormone levels, slender body type, certain medications, nutritional deficiencies, and lifestyle choices, and these factors can increase the risk of developing osteoporosis.
